{"product_id":"vaccine-design-methods-and-protocols-volume-3-resources-for-vaccine-development-9781071618943","title":"Vaccine Design: Methods and Protocols, Volume 3. Resources for Vaccine Development","description":"\u003cp\u003ePART I TRENDS IN VACCINE DEVELOPMENT\u003c\/p\u003e \u003cp\u003e1. Artificial Intelligence for Vaccine Design\u003c\/p\u003e \u003cp\u003ePeter McCaffrey\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e2. Progress in the Development of Structure-Based Vaccines\u003c\/p\u003e \u003cp\u003eSunil Thomas and Ann Abraham\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e3. Polymer-Peptide Conjugate Vaccine for Oral Immunization\u003c\/p\u003e \u003cp\u003eMohammad Omer Faruck, Mariusz Skwarczynski, and Istvan Toth\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e4. An update on \"Reverse Vaccinology\" The Pathway from Genomes and Epitope Predictions to Tailored, Recombinant Vaccines\u003c\/p\u003e \u003cp\u003eMarcin Michalik, Bardya Djahanshiri, Jack C. Leo, and Dirk Linke\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003ePART II VACCINE VECTORS AND PRODUCTION SYSTEM\u003c\/p\u003e \u003cp\u003e5. Phage T7 as a Potential Platform for Vaccine Development\u003c\/p\u003e \u003cp\u003eChuan Loo Wong, Chean Yeah Yong and Khai Wooi Lee\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e6. Plant-based Systems for Vaccine Production\u003c\/p\u003e \u003cp\u003eMattia Santoni, Elisa Gecchele, Roberta Zampieri, and Linda Avesani\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e 7. Production of a Hepatitis E Vaccine Candidate Using the Pichia pastoris Expression System\u003cp\u003e\u003c\/p\u003e \u003cp\u003eJyoti Gupta, Amit Kumar, and Milan Surjit\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e PART III VACCINE ADJUVANTS\u003cp\u003e\u003c\/p\u003e \u003cp\u003e8. Developments in Vaccine Adjuvants\u003c\/p\u003e \u003cp\u003eFarrhana Ziana Firdaus, Mariusz Skwarczynski, and Istvan Toth\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e9. Adjuvants: Engineering Protective Immune Responses in Human and Veterinary Vaccines\u003c\/p\u003e \u003cp\u003eBassel Akache, Felicity C. Stark, Gerard Agbayani, Tyler M. Renner and Michael J. McCluskie\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e10. Cationic Nanostructures as Adjuvants for Vaccines \u003c\/p\u003e Ana Maria Carmona-Ribeiro, Beatriz Ideriha Mathiazzi, and Yunys Pérez-Betancourt\u003cp\u003e\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e11. Emulsion Adjuvants for Use in Veterinary Vaccines\u003c\/p\u003e \u003cp\u003eRachel Madera, Yulia Burakova, and Jishu Shi\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e12. Generation of a Liposomal Vaccine Adjuvant Based on Sulfated S-lactosylarchaeol (SLA) Glycolipids\u003c\/p\u003e \u003cp\u003eBassel Akache, Yimei Jia, Vandana Chandan, Lise Deschatelets and Michael J. McCluskie\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e13. Glucan particles: choosing the appropriate size to use as a vaccine adjuvant\u003c\/p\u003e \u003cp\u003eMariana Colaço, João Panão Costa, and Olga Borges\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003ePART IV VACCINE DELIVERY SYSTEMS \u003c\/p\u003e \u003cp\u003e14. Use of Optical In Vivo Imaging to Monitor and Optimize Delivery of Novel Plasmid-Launched Live-Attenuated Vaccines\u003c\/p\u003e \u003cp\u003eSapna Sharma and Kai Dallmeier\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e15. Liposomes for the Delivery of Lipopeptide Vaccines\u003c\/p\u003e \u003cp\u003eJieru Yang, Armira Azuar, Istvan Toth, and Mariusz Skwarczynski\u003c\/p\u003e \u003cp\u003e\u003c\/p\u003e \u003cp\u003e16. Current Prospects in Peptide-Based Subunit Nanovaccines\u003c\/p\u003e \u003cp\u003ePrashamsa Koirala, Sahra Bashiri, Istvan Toth, and Mariusz Skwarczynski\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e17. Design and Synthesis of Protein-based Nanocapsule Vaccines\u003c\/p\u003e \u003cp\u003eIvana Skakic, Jasmine. E. Francis, and Peter. M. Smooker\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e18. Design and Preparation of Solid Lipid Nanoparticle (SLN) Mediated DNA Vaccines\u003c\/p\u003e \u003cp\u003eJasmine. E. Francis, Ivana Skakic, and Peter. M. Smooker\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e19. Nano-Particulate Platforms for Vaccine Delivery to Enhance Antigen-Specific CD8\u003csup\u003e+\u003c\/sup\u003e T Cell Response\u003c\/p\u003e \u003cp\u003eJhanvi Sharma, Carcia S. Carson, Trevor Douglas, John T. Wilson, and Sebastian Joyce\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e20. PilVax: A Novel Platform for the Development of Mucosal Vaccines\u003c\/p\u003e \u003cp\u003eCatherin\u003cbr\u003e\u003cbr\u003e\u003cb\u003eAuthor:\u003c\/b\u003e Sunil Thomas\u003cbr\u003e\u003cb\u003ePublisher:\u003c\/b\u003e Humana\u003cbr\u003e\u003cb\u003ePublished:\u003c\/b\u003e 12\/18\/2022\u003cbr\u003e\u003cb\u003ePages:\u003c\/b\u003e 546\u003cbr\u003e\u003cb\u003eBinding Type:\u003c\/b\u003e Paperback\u003cbr\u003e\u003cb\u003eWeight:\u003c\/b\u003e 2.13lbs\u003cbr\u003e\u003cb\u003eSize:\u003c\/b\u003e 10.00h x 7.00w x 1.14d\u003cbr\u003e\u003cb\u003eISBN:\u003c\/b\u003e 9781071618943\u003c\/p\u003e","brand":"Humana","offers":[{"title":"Paperback","offer_id":40997200199795,"sku":"9.78107E+12","price":209.95,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0555\/9255\/0515\/products\/img_7c80209c-8516-42f7-bce7-64660b17f8ad.jpg?v=1696948039","url":"https:\/\/bookstorenmore.com\/en-de\/products\/vaccine-design-methods-and-protocols-volume-3-resources-for-vaccine-development-9781071618943","provider":"Bookstore N More","version":"1.0","type":"link"}